Compounds > 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline
Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Graft-Versus-Host Disease

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Graft-Versus-Host Disease in 2 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cetkovic-Cvrlje, M2
Uckun, FM2
Roers, BA1
Waurzyniak, B1
Liu, XP1

Other Studies

2 other studies available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Graft-Versus-Host Disease

ArticleYear
Dual targeting of Bruton's tyrosine kinase and Janus kinase 3 with rationally designed inhibitors prevents graft-versus-host disease (GVHD) in a murine allogeneic bone marrow transplantation model.
    British journal of haematology, 2004, Volume: 126, Issue:6

    Topics: Acute Disease; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Bone Marrow Transplantation; Dr

2004
Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Acute Disease; Animals; Bone Marrow Transplantation; Cell Transplantation; Drug Evaluation, Preclini

2001